References
- Mizuno M, Yamada J, Terai H, Kozukue N, Lee YS, Tsuchida H. (1994). Differences in immunomodulating effect between wild and cultured panax ginseng. Biochem Biophys Res Commun, 200:1672–1678.
- Kim HS, Lee JH, Goo YS, Nah SY. (1998). Effects of ginsenosides on Ca2+ channels and membrane capacitance in rat adrenal chromaffin cells. Brain Res Bull, 46:245–251.
- Ro JY, Ahn YS, Kim KH. (1998). Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions. Int J Immunopharmacol, 20:625–641.
- Surh YJ, Na HK, Lee JY, Keum YS. (2001). Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer. J Korean Med Sci, 16 Suppl:S38–S41.
- Kaneko H, Nakanishi K. (2004). Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, korean red ginseng: specifically, its anti-stress action for prevention of disease. J Pharmacol Sci, 95:158–162.
- Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DT et al. (2007)). Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med, 2:6.
- Gang L, Zhenhua W, Yaxuan S, Ke L, Ziren W. (2006). Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells. Basic Clin Pharmacol Toxicol, 98:588–592.
- Liu GY, Bu X, Yan H, Jia WW. (2007). 20S-protopanaxadiol-induced programmed cell death in glioma cells through caspase-dependent and -independent pathways. J Nat Prod, 70:259–264.
- Popovich DG, Kitts DD. (2004). Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells. J Biochem Mol Toxicol, 18:143–149.
- Chen SE, Sawchuk RJ, Staba EJ. (1980). American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. Eur J Drug Metab Pharmacokinet, 5:161–168.
- Hasegawa H, Sung JH, Benno Y. (1997). Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med, 63:436–440.
- Hasegawa H, Sung JH, Matsumiya S. (1996). Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med, 62:453–457.
- Kubo H, Osawa T, Takashima K, Mizobe M. (1996). Enhancement of oral bioavailability and pharmacological effect of 1-(3,4-dimethoxyphenyl)-2,3-bis(methoxycarbonyl)-4-hydroxy-6,7,8- trimethoxynaphthalene (TA-7552), a new hypocholesterolemic agent, by micronization in co-ground mixture with D-mannitol. Biol Pharm Bull, 19:741–747.
- Martis L, Hall NA, Thakkar AL. (1972). Micelle formation and testosterone solubilization by sodium glycocholate. J Pharm Sci, 61:1757–1761.
- Rees JA, Collett JH. (1974). The dissolution of salicylic acid in micellar solutions of polysorbate 20. J Pharm Pharmacol, 26:956–960.
- Cassella R, Williams DA, Jambhekar SS. (1998). Solidstate–cyclodextrin complexes containing indomethacin, ammonia and water. II. Solubility studies. Int J Pharm, 165:15–22.
- Trapani G, Latrofa A, Franco M, Lopedota A, Maciocco E, Liso G. (1998). Water-soluble salts of aminoacid esters of the anaesthetic agent propofol. Int J Pharm, 175:195–204.
- Suleiman MS, Najib N, el-Sayed Y, Hasan M, Abdulahameed M. (1989). A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium. Int J Clin Pharmacol Ther Toxicol, 27:276–279.
- Dammann HG, Simon-Schultz J, Steinhoff I, Damaschke A, Schmoldt A, Sallowsky E. (1993). Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms. Br J Clin Pharmacol, 36:345–349.
- Dhirendra K, Lewis S, Udupa N, Atin K. (2009). Solid dispersions: a review. Pak J Pharm Sci, 22:234–246.
- Jennifer BD, Christos R. (2000). In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci, 2:73–80.
- Paek IB, Moon Y, Kim J, Ji HY, Kim SA, Sohn DH et al. (2006). Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm Drug Dispos, 27:39–45.
- Bruce JA, Hiroshi S, Deborah LB, Shiew-Mei H, Shaker AM, Munir A. (1996). Hussain Enhancement of the intestinal absorption of peptides and nonpeptides. J Control Release, 41:19–31.
- Kaus LC, Gillespie WR, Hussain AS, Amidon GL. (1999). The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities. Pharm Res, 16:272–280.
- Meihua H, Jing C, Shilin C, Xiangtao W. (2010). Development of a UPLC-ESI-MS/MS Assay for 20(S)-Protopanaxadiol and Pharmacokinetic Application of Its Two Formulations in Rats. Anal Sci, 26:749–753.